Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4754629
Max Phase: Preclinical
Molecular Formula: C44H44ClN7O5S
Molecular Weight: 818.40
Molecule Type: Unknown
Associated Items:
ID: ALA4754629
Max Phase: Preclinical
Molecular Formula: C44H44ClN7O5S
Molecular Weight: 818.40
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC#Cc1sc2ncnc(N[C@H](Cc3ccccc3OCc3ccnc(-c4ccccc4OC)n3)C(=O)O)c2c1-c1ccc(OCCN2CCN(C)CC2)c(Cl)c1C
Standard InChI: InChI=1S/C44H44ClN7O5S/c1-5-10-37-38(31-15-16-36(40(45)28(31)2)56-24-23-52-21-19-51(3)20-22-52)39-42(47-27-48-43(39)58-37)50-33(44(53)54)25-29-11-6-8-13-34(29)57-26-30-17-18-46-41(49-30)32-12-7-9-14-35(32)55-4/h6-9,11-18,27,33H,19-26H2,1-4H3,(H,53,54)(H,47,48,50)/t33-/m1/s1
Standard InChI Key: IEFFHFKXSCXKRI-MGBGTMOVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 818.40 | Molecular Weight (Monoisotopic): 817.2813 | AlogP: 7.47 | #Rotatable Bonds: 15 |
Polar Surface Area: 135.06 | Molecular Species: ACID | HBA: 12 | HBD: 2 |
#RO5 Violations: 3 | HBA (Lipinski): 12 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.16 | CX Basic pKa: 7.65 | CX LogP: 5.49 | CX LogD: 5.36 |
Aromatic Rings: 6 | Heavy Atoms: 58 | QED Weighted: 0.10 | Np Likeness Score: -0.85 |
1. Szlavik Z,Csekei M,Paczal A,Szabo ZB,Sipos S,Radics G,Proszenyak A,Balint B,Murray J,Davidson J,Chen I,Dokurno P,Surgenor AE,Daniels ZM,Hubbard RE,Le Toumelin-Braizat G,Claperon A,Lysiak-Auvity G,Girard AM,Bruno A,Chanrion M,Colland F,Maragno AL,Demarles D,Geneste O,Kotschy A. (2020) Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor., 63 (22): [PMID:33146521] [10.1021/acs.jmedchem.0c01234] |
Source(1):